Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronJuan Manuel Carreño, Florian Krammer, Angela A. Amoako et al.|Nature|2021Cited by 531
Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronJuan Manuel Carreño, Florian Krammer, Hala Alshammary et al.|Nature|2021Cited by 100
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipientsJuan Manuel Carreño, Viviana Simon, Hala Alshammary et al.|EBioMedicine|2021Cited by 55
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccinationJuan Manuel Carreño, Florian Krammer, Ariel Raskin et al.|Science Translational Medicine|2023Cited by 23
Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37Juan Manuel Carreño, Viviana Simon, Hala Alshammary et al.|medRxiv|2021Cited by 18